BioWorld MedTech

Jan. 12, 2015

View Archived Issues

InVivo reopens enrollment for Neuro-Spinal Scaffold

InVivo Therapeutics (Cambridge, Massachusetts) reported the reopening of subject enrollment for the company's ongoing pilot trial of its investigational Neuro-Spinal Scaffold in patients with acute spinal cord injury. Read More

It's Complicated: Genome studies broaden and deepen as methods progress

Read More

FDA grants CLIA waiver for molecular diagnostic test for influenza A & B

Read More

Inside the Beltway: Palmetto's Putcha: FDA oversight of LDTs could push testing to clinics

Read More

Attached to today's issue: The MDD 4Q Report.

Read More

Financings: PureTech closes on $50 million growth stage investment round

Read More

Report from Europe; Mauna Kea reports its sales are up 10% despite 'sharply contrasting trends'

Read More

HIT Bits: Mirth to power patient health information for Arizona network

Read More

MDD's Stock Market Winners and Losers

Read More

MDD's Stock Report for the week of 1/2-1/9

Read More

Briefly noted

Read More

People in Places

Read More

Product briefs

Read More

MDD's Neurology Extra

Read More

MDD's 4Q Report: Mergers and Acquisitions: Fewer, but more valuable, deals are the trend for last quarter of 2014

Read More

4Q14 Deals Chart

Read More

MDD's 4Q Report: Financings: Series A funding and IPOs show steady resolve in 4Q14

Read More

4Q14 Financial Chart

Read More

MDD's 4Q Report: Inside the Beltway FDA publishes revised draft guidance for LDT regulation

Read More

MDD's 4Q Report: Agreements/contracts: End of year slows down a bit, but still sees quality partnerships

Read More